Skip to main content
. 2020 May 8;2020:2616024. doi: 10.1155/2020/2616024

Figure 2.

Figure 2

Tetrandrine treatment improved cardiac function in DOX-treated mice. (a) Heart rate in the indicated groups (n = 8). (b–d) Alterations in +dP/dt, LVSP, and EF in mice (n = 8). (e, f) Cardiac output and stroke work of mice (n = 8). (g–i) LVEDP and Tau values (n = 8). (j–l) PRSW, dP/dt-EDV, and Emax of the mice (n = 8). P < 0.05 compared with the saline group. #P < 0.05 compared with mice after DOX injection.